- 24 h
- letzte 200 News
| Zeit | Aktuelle Nachrichten | ||
|---|---|---|---|
| 18.02. | Recipharm focuses footprint with sale of Israel API plant, new CDMO partnership | ||
| 18.02. | Senate HELP Committee chair pitches proposals for FDA reform | ||
| 18.02. | J&J fleshes out US investment plan, telegraphing $1B cell therapy plant and 500 new jobs in PA | ||
| 18.02. | With an assist from Shaq, Lilly joins Team USA's work to help Olympic athletes rebound from injury | ||
| 18.02. | Novartis heads to FDA with Rhapsido after phase 3 win in untapped chronic hives subtype | ||
| 18.02. | Lilly chalks up another trial win for Zepbound-Taltz combo in bid to break down psoriasis, obesity 'silos' | ||
| 17.02. | Stada earmarks €85M to build out Middle East production hub in Saudi Arabia | ||
| 17.02. | Bayer strikes $7.25B Roundup settlement, favoring 'speed and containment' of thorny legal issue | ||
| 17.02. | 'Hypertension Bites': AstraZeneca-backed coalition launches '90s-inspired awareness campaign | ||
| 17.02. | Ocular Therapeutix eyes FDA filing with ph. 3 wet AMD win over Eylea, but investors balk | ||
| 17.02. | Lilly's rare cancer drug Retevmo looks to broaden reach with adjuvant trial win | ||
| 17.02. | Roche adds to Gazyva's growing autoimmune pedigree with new phase 3 kidney condition win | ||
| 17.02. | Sanofi bids adieu to specialty care chief, promotes Manuela Buxo to assume key post | ||
| 17.02. | Novartis taps Niowave for long-term supply of radiopharmaceutical isotope | ||
| 13.02. | Lilly's pre-launch inventory of oral GLP-1 candidate swells ahead of expected FDA obesity nod | ||
| 13.02. | Astellas casts retina specialists as 'Partners in Protection' in Izervay HCP campaign | ||
| 13.02. | Busy with Casgevy and Journavx launches, Vertex sets ambitious $500M revenue goal for non-CF meds this year | ||
| 13.02. | With the FDA's Moderna decision, vaccine makers face increasingly uncertain regulatory environment | ||
| 13.02. | Bayer and celebrity chef keep diners in the dark to shed light on heart health | ||
| 13.02. | Novartis to seek full FDA approval for IgAN drug Vanrafia despite missing ph. 3 kidney function goal | ||
| 13.02. | PTC shuts down FDA approval bid for troubled Duchenne med Translarna | ||
| 12.02. | Amid Wegovy pill's flying start in US, Novo CEO eyes Ireland expansion for supply overseas: Bloomberg | ||
| 12.02. | AbbVie mounts fresh IRA legal challenge over Botox's inclusion in latest drug pricing negotiations list | ||
| 12.02. | Alnylam turns profitable even as Amvuttra ATTR revenue disappoints in Q4 | ||
| 12.02. | Supreme seasons creative agency portfolio with Broth buyout |
Sie erhalten auf FinanzNachrichten.de kostenlose Realtime-Aktienkurse von und sowie Kurse und Daten von ARIVA.DE AG.